🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether ATIR is safe and effectiv...
Status
Completed
Location
Algemeen Ziekenhuis Sint-Jan
Start Date
2013-03
Trial ID
NCT01794299
Treatments Being Tested
The purpose of this study is to investigate the safety and feasibility of g...
Status
Recruiting
Location
Columbia University Irving Medical Center/NYP
Start Date
2021-10-22
Trial ID
NCT04804891
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
This is a research study involving the treatment of patients with hematolog...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2011-04
Trial ID
NCT01350258
This is an observational study to evaluate safety and efficacy outcomes in ...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2018-01-23
Trial ID
NCT03326076
This is a phase I, prospective clinical trial studying the safety and feasi...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2025-09-25
Trial ID
NCT07052370
In this Phase I study, the study team will evaluate the safety of Valproic ...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-02-21
Trial ID
NCT03885947
Treatments Being Tested
Ovarian cancer (OC) is one of the most lethal cancers in the world due to l...
Status
Recruiting
Location
Catharina Hospital
Start Date
2025-01-01
Trial ID
NCT06611072
Treatments Being Tested